Global POC Lipid Testing Market 2015-2019

About POC Lipid Testing
POC lipid testing helps determine blood lipid levels, which includes the measurement of total cholesterol, LDL, HDL, and triglyceride levels. The results are obtained quickly and, therefore, helps provide rapid treatments and medication to a patient. The increasing incidence of lifestyle diseases such as obesity, diabetes, and cardiac disease is responsible for establishing POC lipid testing worldwide; it is cost-effective and user-friendly. POC lipid testing products are standardized to minimize errors during testing.
TechNavio's analysts forecast the Global POC Lipid Testing market to grow at a CAGR of 6.04 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global POC Lipid Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC lipid testing products used for various applications including:
‧ Total cholesterol testing
‧ HDL testing
‧ LDL testing
‧ Triglycerides testing
TechNavio's report, the Global POC Lipid Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Lipid Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Abbott Laboratories
‧ Alere
‧ F. Hoffmann-La Roche
‧ PTS
Other Prominent Vendors

‧ A. Menarini Diagnostics
‧ Abaxis
‧ Accutech
‧ Acon
‧ Bayer Healthcare
‧ BD
‧ bioMerieux
‧ Bio-Rad Laboratories
‧ Corgenix
‧ Danaher
‧ Eurotrol
‧ General Life Biotechnology
‧ Helena Laboratories
‧ Nova Biomedical
‧ OraSure Technologies
‧ Quidel
‧ Randox Laboratories
‧ Sekisui Diagnostics
‧ Siemens Healthcare
‧ Sysmex
‧ Trinity Biotech


Market Driver
‧ Increase in Obesity and Cardiac Disorders
‧ For a full, detailed list, view our report
Market Challenge
‧ Threat of Laboratory Lipid Testing
‧ For a full, detailed list, view our report
Market Trend
‧ Increased Adoption of POC Lipid Testing
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2019 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 World Population
06.1.1 Forecast of World Population
06.2 Incidence of Obesity
06.2.1 Forecast of World Population
06.3 Percentage of Population Suffering from Obesity
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 POC Lipid Testing Market in US
07.3.1 Market Size and Forecast
07.4 POC Lipid Testing Market in Europe
07.4.1 Market Size and Forecast
07.5 Five Forces Analysis
08. Market Segmentation by Application
09. Geographical Segmentation
09.1 POC Lipid Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 POC Lipid Testing Market in EMEA Region
09.2.1 Market Size and Forecast
09.3 POC Lipid Testing Market in APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Vendor Analysis 2014
17.2.1 Popular Products Portfolio
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue
18.1.4 Business Segmentation by Revenue 2011 and 2012
18.1.5 Geographical Segmentation by Revenue
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Alere
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Geographical Segmentation by Revenue 2013
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 F. Hoffmann-La Roche
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation
18.3.4 Geographical Segmentation by Revenue 2013
18.3.5 Business Strategy
18.3.6 Key Information
18.3.7 SWOT Analysis
18.4 PTS Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Recent Developments
18.4.4 SWOT Analysis
19. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: World Population 2014-2019 (million)
Exhibit 3: Incidence of Obesity 2014-2019 (million)
Exhibit 4: Percentage of World Population Suffering from Obesity 2014-2019
Exhibit 5: Global POC Lipid Testing Market 2014-2019 (US$ million)
Exhibit 6: POC Lipid Testing Market in US 2014-2019 (US$ million)
Exhibit 7: POC Lipid Testing Market in Europe 2014-2019 (US$ million)
Exhibit 8: Segmentation of Global POC Lipid Testing Market by Application
Exhibit 9: Geographical Segmentation of Global POC Lipid Testing Market 2014 and 2019
Exhibit 10: POC Lipid Testing Market in Americas 2014-2019 (US$ million)
Exhibit 11: POC Lipid Testing Market in EMEA Region 2014-2019 (US$ million)
Exhibit 12: POC Lipid Testing Market in APAC Region 2014-2019 (US$ million)
Exhibit 13: Geographical Segmentation of Global POC Lipid Testing Market 2014-2019 (US$ million)
Exhibit 14: Geographical Segmentation of Global POC Lipid Testing Market 2014-2019
Exhibit 15: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 16: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 17: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 18: Global POC Lipid Testing Market: Business Segmentation by Revenue 2013
Exhibit 19: Global POC Lipid Testing Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 20: Global POC Lipid Testing Market: Geographical Segmentation by Revenue 2013
Exhibit 21: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 23: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 24: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)